These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
306 related articles for article (PubMed ID: 33621953)
1. Identification of a ten-long noncoding RNA signature for predicting the survival and immune status of patients with bladder urothelial carcinoma based on the GEO database: a superior machine learning model. Mao X; Chen S; Li G Aging (Albany NY); 2021 Feb; 13(5):6957-6981. PubMed ID: 33621953 [TBL] [Abstract][Full Text] [Related]
2. An autophagy-related long non-coding RNA prognostic signature accurately predicts survival outcomes in bladder urothelial carcinoma patients. Sun Z; Jing C; Xiao C; Li T Aging (Albany NY); 2020 Aug; 12(15):15624-15637. PubMed ID: 32805727 [TBL] [Abstract][Full Text] [Related]
3. Identification of an immune-related long non-coding RNA signature and nomogram as prognostic target for muscle-invasive bladder cancer. Song Y; Jin D; Chen J; Luo Z; Chen G; Yang Y; Liu X Aging (Albany NY); 2020 Jun; 12(12):12051-12073. PubMed ID: 32579540 [TBL] [Abstract][Full Text] [Related]
4. An effective N6-methyladenosine-related long non-coding RNA prognostic signature for predicting the prognosis of patients with bladder cancer. Ma T; Wang X; Meng L; Liu X; Wang J; Zhang W; Tian Z; Zhang Y BMC Cancer; 2021 Nov; 21(1):1256. PubMed ID: 34802433 [TBL] [Abstract][Full Text] [Related]
5. A potential prognostic lncRNA signature for predicting survival in patients with bladder urothelial carcinoma. Bao Z; Zhang W; Dong D Oncotarget; 2017 Feb; 8(6):10485-10497. PubMed ID: 28060759 [TBL] [Abstract][Full Text] [Related]
6. Identification of cuproptosis-related long non-coding RNA and construction of a novel prognostic signature for bladder cancer: An observational study. Ye Z; Liu C; Wu S; Jin X; Lin H; Wang T; Zheng Q; Guo Z Medicine (Baltimore); 2024 May; 103(18):e38005. PubMed ID: 38701267 [TBL] [Abstract][Full Text] [Related]
7. Multi-Omics analysis identifies a lncRNA-related prognostic signature to predict bladder cancer recurrence. Xu Z; Chen H; Sun J; Mao W; Chen S; Chen M Bioengineered; 2021 Dec; 12(2):11108-11125. PubMed ID: 34738881 [TBL] [Abstract][Full Text] [Related]
8. A novel cuproptosis-related lncRNA signature predicts the prognosis and immune landscape in bladder cancer. Bai Y; Zhang Q; Liu F; Quan J Front Immunol; 2022; 13():1027449. PubMed ID: 36451815 [TBL] [Abstract][Full Text] [Related]
9. Development of a novel six-long noncoding RNA signature predicting survival of patients with bladder urothelial carcinoma. Gao X; Zhang S; Chen Y; Wen X; Chen M; Wang S; Zhang Y J Cell Biochem; 2019 Dec; 120(12):19796-19809. PubMed ID: 31338862 [TBL] [Abstract][Full Text] [Related]
10. Comprehensive analysis of cuproptosis-related lncRNAs signature to predict prognosis in bladder urothelial carcinoma. Zhu S; Li H; Fan Y; Tang C BMC Urol; 2023 Jul; 23(1):124. PubMed ID: 37479989 [TBL] [Abstract][Full Text] [Related]
11. Identification of five long noncoding RNAs signature and risk score for prognosis of bladder urothelial carcinoma. Zhang C; Li Z; Hu J; Qi F; Li X; Luo J J Cell Biochem; 2020 Jan; 121(1):856-866. PubMed ID: 31373406 [TBL] [Abstract][Full Text] [Related]
12. A robust signature of immune-related long non-coding RNA to predict the prognosis of bladder cancer. Lai C; Wu Z; Li Z; Yu H; Li K; Tang Z; Liu C; Xu K Cancer Med; 2021 Sep; 10(18):6534-6545. PubMed ID: 34374227 [TBL] [Abstract][Full Text] [Related]
13. Identifying a Novel Defined Pyroptosis-Associated Long Noncoding RNA Signature Contributes to Predicting Prognosis and Tumor Microenvironment of Bladder Cancer. Lu H; Wu J; Liang L; Wang X; Cai H Front Immunol; 2022; 13():803355. PubMed ID: 35154117 [TBL] [Abstract][Full Text] [Related]
14. Prognosis analysis and validation of lipid metabolism-associated lncRNAs and tumor immune microenvironment in bladder cancer. Tan Z; Fu S; Zuo J; Wang J; Wang H Aging (Albany NY); 2023 Aug; 15(16):8384-8407. PubMed ID: 37632832 [TBL] [Abstract][Full Text] [Related]
15. Predicting Prognosis and Distinguishing Cold and Hot Tumors in Bladder Urothelial Carcinoma Based on Necroptosis-Associated lncRNAs. Liu D; Xu S; Chang T; Ma S; Wang K; Sun G; Chen S; Xu Y; Zhang H Front Immunol; 2022; 13():916800. PubMed ID: 35860239 [TBL] [Abstract][Full Text] [Related]
16. Identification of immune-related LncRNA for predicting prognosis and immunotherapeutic response in bladder cancer. Wu Y; Zhang L; He S; Guan B; He A; Yang K; Gong Y; Li X; Zhou L Aging (Albany NY); 2020 Nov; 12(22):23306-23325. PubMed ID: 33221763 [TBL] [Abstract][Full Text] [Related]
17. Identification and verification of an immune-related lncRNA signature for predicting the prognosis of patients with bladder cancer. Wang J; Shen C; Dong D; Zhong X; Wang Y; Yang X Int Immunopharmacol; 2021 Jan; 90():107146. PubMed ID: 33189610 [TBL] [Abstract][Full Text] [Related]
18. Uncovering the potential functions of lymph node metastasis-associated aberrant methylation differentially expressed genes and their association with the immune infiltration and prognosis in bladder urothelial carcinoma. Gao W; Zhang J; Tian T; Fu Z; Bai L; Yang Y; Wu Q; Wang W; Guo Y PeerJ; 2023; 11():e15284. PubMed ID: 37123010 [TBL] [Abstract][Full Text] [Related]
19. RNA-Sequencing Data Reveal a Prognostic Four-lncRNA-Based Risk Score for Bladder Urothelial Carcinoma: An in Silico Update. He RQ; Huang ZG; Li TY; Wei YP; Chen G; Lin XG; Wang QY Cell Physiol Biochem; 2018; 50(4):1474-1495. PubMed ID: 30359990 [TBL] [Abstract][Full Text] [Related]
20. Development of a prognostic model to predict BLCA based on anoikis-related gene signature: preliminary findings. Zhu S; Zhao Q; Fan Y; Tang C BMC Urol; 2023 Dec; 23(1):199. PubMed ID: 38049825 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]